Rose Nono-Lin absent during Senate hearing due to COVID-19 | Inquirer News

Rose Nono-Lin absent during Senate hearing due to COVID-19

/ 05:30 PM January 27, 2022


MANILA, Philippines — Rose Nono-Lin, who was linked to the controversy involving Pharmally Pharmaceutical Corp., was a no show during the Senate blue ribbon committee hearing because she contracted COVID-19.

“We sent a subpoena to Rose Nono-Lin. But this afternoon, her lawyers sent a letter, seeking that she be excused because she had tested positive for COVID among other gastro-illnesses and body malaise,” said Rodolfo Noel Quimbo, director-general of the Senate panel’s oversight office management, during Thursday’s hearing.


Senator Richard Gordon, panel chair, was skeptical about Nono-Lin’s absence.

“It’s quite extraordinary that every time we have hearing, Ms. Nono-Lin refuses to testify for some reason or another,” Gordon said.


“First it was the typhoon and now, she suddenly had COVID. Medical certificate to accompany that?,” he added.

Quimbo then shared what the medical certificate contained.

“A medical certificate has accompanied the letter. It was issued by Maria Millicent Cariño. She is a laparoscopic and hepato-pancreato-biliary surgeon and she says that Ms. Nono-Lin is for admission for further work up, chest X-ray, CT scan, creatinine, [complete blood count], urinalysis, and other tests,” Quimbo said.

“The doctor also says that she will be referred to an infectious disease specialist and an internal medicine/pulmonology doctor, Your Honor,” he continued.

Gordon ordered Quimbo to look into the doctor because of his doubts.

“To give her benefit of the doubt, but I’m not willing to give the benefit of the doubt, to doctors who might be friendly enough to provide for a medical certificate, and I just warn these doctors that they give us a false medical certificate, they would be responsible for it,” the chair cautioned.

“Kung makakapagkampanya siya at kung itong hearing na ito ay hindi niya ma-attend-an, napakadali sa taong may pera na nagkakaanak ng kotse sa kanyang garahe, every time she looks at the garahe may bagong kotse, nakakapagtaka lang na hindi mo maalis sa akin magduda, bilang isang quack doctor, na biglang irarason na hindi siya makakarating dito,” Gordon pointed out.


(If she could campaign and not attend this hearing, it is easy for a rich person who has a garage birthing a car, I am wondering and you cannot remove my doubts on why she cannot go here.)

Nono-Lin was quizzed about a luxury car registered to her name during a previous hearing, which she said she just found out in their garage.

Nono-Lin is also gunning for a congressional seat in the upcoming elections.

Nono-Lin, along with four other people linked to the controversy involving Pharmally, was cited in contempt for snubbing the hearings. The others were Gerald Cruz, Jayson Uson, Sophia Custodio, and Dennis Manalastas.

The Senate blue ribbon committee has been conducting an inquiry on the government’s procurement of COVID-19 supplies in 2020.

Based on the Senate’s investigations, Pharmally bagged government deals worth billions of pesos for various medical supplies despite having a paid-up capital of only P625,000.


Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: blue ribbon committee, hearings, pandemic, Pharmally, Rose Nono Lin, Senate
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

© Copyright 1997-2022 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.